Drugs that contain Edoxaban Tosylate

1. List of Savaysa drug patents

SAVAYSA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7365205 DAIICHI SANKYO INC Diamine derivatives
Apr, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9149532 DAIICHI SANKYO INC Pharmaceutical composition
Mar, 2028

(4 years from now)

Exclusivity Exclusivity Expiration
M (M) Aug 9, 2022

Market Authorisation Date: 08 January, 2015

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of SAVAYSA before it's patent expiration?
More Information on Dosage

SAVAYSA family patents

15

Japan

11

United States

4

South Africa

4

Mexico

4

Norway

4

Poland

4

China

4

European Union

3

Israel

3

Australia

3

Russia

3

Brazil

3

Spain

3

Korea, Republic of

3

Canada

2

Denmark

2

Hong Kong

2

Lithuania

2

Hungary

2

Argentina

2

Portugal

2

Cyprus

2

Malaysia

2

Taiwan, Province of China

2

New Zealand

1

Austria

1

Belgium

1

Slovenia

1

Philippines

1

Colombia

1

Croatia

1

Singapore

1

Netherlands

1

Luxembourg

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic